Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses ———— — Research & development ———— — Operating income 800 M692 M619 M984 M 3.1 B Non-Operating Income, Total -28 M-9 M-6 M-59 M -102 M Interest expense, net of interest capitalized 4 M3 M4 M35 M 46 M Non-Operating Income, excl. Interest Expenses -4 M-3 M-4 M-35 M -46 M Unusual income/expense -28 M-9 M-6 M-59 M -102 M Pretax income 600 M510 M445 M721 M 2.28 B Equity in earnings ———— — Taxes 124 M121 M105 M169 M 519 M Non-controlling/minority interest ———— — After tax other income/expense -8 M43 M5 M0 40 M Net income before discontinued operations 476 M389 M340 M552 M 1.76 B Discontinued operations ———— — Net income 476 M389 M340 M552 M 1.76 B Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 476 M389 M340 M1.67 B 2.87 B Basic earnings per share (Basic EPS) 0.990.810.711.16 3.67 Diluted earnings per share (Diluted EPS) 0.990.810.713.47 3.66 Average basic shares outstanding 478.76 M479.35 M479.34 M479.12 M — Diluted shares outstanding 480.37 M480.66 M481.19 M480.61 M — EBITDA 804 M695 M623 M— — EBIT 800 M692 M619 M— — Cost of revenue 17.25 B16.97 B16.71 B17.99 B 68.91 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 4 M3 M4 M35 M 46 M